BioMed Research International / 2017 / Article / Tab 1

Research Article

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation

Table 1

Characteristics of atrial fibrillation (AF) patients and controls.

VariablesAF groupnon-AF control group value

Number of patients after exclusions2414
Age (years)56.45 (47.43–59.80)50.60 (32.80–56.10)0.061
Male, (%)15 (62.50)10 (71.43)0.728
BMI (kg/m2)29.43 ± 5.5226.10 ± 4.750.068
Cerebrovascular risk factors, (%)
 Arterial hypertension13 (54.17)8 (57.14)1.000
 Hypercholesterolemia19 (79.17)8 (57.14)0.266
 Current smoking2 (8.33)6 (42.86)0.013
 Diabetes mellitus2 (8.33)0
Previous myocardial infarction, (%)00
Previous ischemic stroke, (%)00
Heart failure, (%)1 (4.17)0
Left atrium size (mm)39.71 ± 4.8236.55 ± 4.800.081
AF period during procedure, (%)2 (8,33)
CHADS2 score, (%)
 010 (41.67)n.a.
 110 (41.67)n.a.
 24 (16.67)n.a.
CHA2DS2-VASC score, (%)
 06 (25.00)n.a.
 19 (37.50)n.a.
 25 (20.83)n.a.
 33 (12.50)n.a.
 41 (4.17)n.a.
EHRA score, (%)
 13 (12.50)n.a.
 21 (4.17)n.a.
 316 (66.67)n.a.
 44 (16.67)n.a.
Medication, (%)
 Statin6 (25.00)2 (14.29)0.684
 ACEI8 (33.33)6 (42.86)0.729
 Beta-blocker17 (70.83)9 (64.29)0.728
Laboratory parameters
 C-reactive protein (mg/L)1.50 (0.60–2.75)1.10 (0.13–2.05)0.281
 Total cholesterol (mmol/L)5.30 ± 1.164.69 ± 1.090.122
 LDL cholesterol (mmol/L)3.42 ± 0.982.79 ± 0.910.061
 HDL cholesterol (mmol/L)1.44 (0.32)1.46 ± 0.420.812
 Triglyceride (mmol/L)1.80 (1.23–2.18)1.4 (0.75–1.95)0.208
Zero blood group, (%)7 (29.17)2 (14.29)0.446

Continuous variables are expressed as mean ± SD or median (interquartile range). Categorical variables are indicated as number (percentage), unless otherwise stated. AF: atrial fibrillation; : number; IQR: interquartile range; SD: standard deviation; n.a.: nonapplicable; BMI: body mass index; CHADS2 score: congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke/transient ischemic attack; CHA2DS2-VASC score: congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, stroke/transient ischemic attack/thromboembolism, vascular disease (prior myocardial infarction, peripheral vascular disease, or aortic atherosclerosis), age (65–74 years), sex category (female); EHRA score: European Heart Rhythm Association score; ACEI: angiotensin converting enzyme inhibitor; LDL cholesterol: low density lipoprotein cholesterol; HDL cholesterol: high density lipoprotein cholesterol.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.